BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 10812498)

  • 1. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
    Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S
    Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory myopathies in Nigerians: case series and literature review.
    Adelowo OO; Edomwonyi U; Olaosebikan H
    Afr J Med Med Sci; 2013 Jun; 42(2):143-9. PubMed ID: 24377199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study.
    Zhong Y; Bai W; Xie Q; Sun J; Tang H; Rao L
    Int J Cardiovasc Imaging; 2018 May; 34(5):683-693. PubMed ID: 29168054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases.
    Scola RH; Werneck LC; Prevedello DM; Toderke EL; Iwamoto FM
    Arq Neuropsiquiatr; 2000 Sep; 58(3B):789-99. PubMed ID: 11018813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatomyositis and polymyositis: new treatment targets on the horizon.
    Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
    Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coexistence of hypothyroidism with polymyositis or dermatomyositis].
    Lukjanowicz M; Bobrowska-Snarska D; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of early treatment in polymyositis and dermatomyositis.
    Naji P; Shahram F; Nadji A; Davatchi F
    Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of age on characteristics of polymyositis and dermatomyositis in adults.
    Marie I; Hatron PY; Levesque H; Hachulla E; Hellot MF; Michon-Pasturel U; Courtois H; Devulder B
    Medicine (Baltimore); 1999 May; 78(3):139-47. PubMed ID: 10352646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased osteopontin in muscle and serum from patients with idiopathic inflammatory myopathies.
    Xiao F; Tan JZ; Xu X; Zhu BL; Fang S; Wang XF
    Clin Exp Rheumatol; 2015; 33(3):399-404. PubMed ID: 25936410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients.
    Koh ET; Seow A; Ong B; Ratnagopal P; Tjia H; Chng HH
    Ann Rheum Dis; 1993 Dec; 52(12):857-61. PubMed ID: 8311535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic changes in dermatomyositis and polymyositis.
    Deveza LM; Miossi R; de Souza FH; Shimabuco AY; Favarato MH; Grindler J; Shinjo SK
    Rev Bras Reumatol Engl Ed; 2016; 56(2):95-100. PubMed ID: 27267520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of polymyositis and dermatomyositis.
    Marie I; Mouthon L
    Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.
    Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A
    Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.